Literature DB >> 18418511

'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.

R M Tan1, S M Chng, W T Seow, J Wong, C C Lim.   

Abstract

Moyamoya syndrome (MMS) is an uncommon association of neurofibromatosis type 1 (NF1). We describe a seven-year-old chinese girl with NF1 and unilateral MMS with multiple hyperintensities on T2-weighted magnetic resonance (MR) images. The ischaemic lesions in the ipsilateral white matter were hypointense on fluid attenuated inversion recovery (FLAIR) MR images, in contrast to the hyperintense "unidentified bright objects" (UBOs) of NF1. Neuroradiologists should be aware of associated MMS in NF1 patients, and distinguish the effects of ischaemia from UBOs, especially on FLAIR MR imaging.

Entities:  

Mesh:

Year:  2008        PMID: 18418511

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  6 in total

1.  Primary central nervous system vasculitis and moyamoya disease: similarities and differences.

Authors:  Markus Kraemer; Peter Berlit
Journal:  J Neurol       Date:  2010-05       Impact factor: 4.849

2.  Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient.

Authors:  Natália Battisti Serafini; Cássio Battisti Serafini; Alanna Santoro Vinhas; Marcio Barbosa Godinho
Journal:  An Bras Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.896

3.  Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report.

Authors:  Hideyuki Arita; Yoshitaka Narita; Makoto Ohno; Yasuji Miyakita; Yoshiko Okita; Takafumi Ide; Soichiro Shibui
Journal:  Childs Nerv Syst       Date:  2012-10-30       Impact factor: 1.475

4.  Reduced cerebral arterial spin-labeled perfusion in children with neurofibromatosis type 1.

Authors:  K W Yeom; R M Lober; P D Barnes; C J Campen
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-13       Impact factor: 3.825

Review 5.  Neurovascular manifestations of connective-tissue diseases: A review.

Authors:  Sarasa T Kim; Waleed Brinjikji; Giuseppe Lanzino; David F Kallmes
Journal:  Interv Neuroradiol       Date:  2016-08-10       Impact factor: 1.610

6.  Moyamoya syndrome and neurofibromatosis type 1.

Authors:  Euthymia Vargiami; Evdoxia Sapountzi; Dimitris Samakovitis; Spyros Batzios; Maria Kyriazi; Athanasia Anastasiou; Dimitrios I Zafeiriou
Journal:  Ital J Pediatr       Date:  2014-06-21       Impact factor: 2.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.